Jeffrey Q. Cao, BSc (Hons), MD, MBA, FRCPC

Radiation Oncologist, Arthur Child Comprehensive Cancer Centre
Clinical Associate Professor, University of Calgary
Medical Lead, Oncology Leadership and Development Office
Provincial Breast Tumour Team Lead, Alberta Health Services
Calgary, AB

Dr. Jeffrey Cao completed his BSc Honours in Pharmacology and MD from the University of Alberta. During residency in Radiation Oncology at the University of Western Ontario, he served on the Board of PAIRO, earned his MBA at the Ivey School of Business and honoured with the Health Sector Highest Contribution Award and nominated Valedictorian. Dr. Cao was the recipient of the OMA Resident Achievement Award upon return to residency and subsequently awarded the CARO Elekta Fellowship for research at the BC Cancer Agency in Vancouver and then received the inaugural CPQR Fellowship with the Canadian Partnership for Quality Radiotherapy. During Fellowship, Dr. Cao served on the CARO Board of Directors and conferred the CARO Extraordinary Contribution Award. He served as Course Director for the 22ndand 25th Annual Canadian Exam Preparation and Review Course for Clinical and Radiation Oncology. He was previously the Chair of the CARO Communications Committee and Treasurer of the Canadian Radiation Oncology Foundation but now the Chair of the Board. Dr. Cao is currently Clinical Associate Professor at the University of Calgary and has transitioned from Lead Breast Radiation Oncologist at the Tom Baker Cancer Centre to Alberta Health Services Provincial Breast Tumour Team Lead. His other subspecialty focus is in Hematological Malignancies including Total Body Irradiation.

 John Walker, MD, FRCPC

Oncologist, Cross Cancer Institute
Edmonton, Alberta

 Brock Debenham, MD, FRCPC, DABR

Section Chief & Academic Division Director, Radiation Oncology
Cross Cancer Institute / University of Alberta
Edmonton, AB

Dr. Debenham completed his residency training at the University of Alberta, and fellowship at Mount Sinai Beth Israel in New York City. His areas of clinical interest are head and neck cancers and lung cancers. He has previously served as program director for the radiation oncology residency program, and as the Assistant Dean, Academic Affairs, for the University of Alberta MD program. He sits on the American Board of Radiology Head and Neck Exam Committee and the NCI Head and Neck Rare Tumor Task Force.

 Corinne Doll, BSc, MD, FRCPC

Clinical Professor, Department of Oncology, University of Calgary
Radiation Oncologist, Arthur J.E. Child Comprehensive Cancer Centre
Calgary, AB

Dr. Corinne Doll is a Clinical Professor in the Department of Oncology at the University of Calgary and Radiation Oncologist at Arthur Child Comprehensive Cancer Centre. Before coming to Calgary she trained at BC Cancer in Vancouver and The Princess Margaret Cancer Centre in Toronto. She is Translational Research and Clinical Gynecologic Brachytherapy Lead, Division of Radiation Oncology, Deputy Medical Director of the Arthur Child Comprehensive Cancer Centre, and Associate Director of Clinical and Population Research for the Charbonneau Cancer Institute. She served two terms as Co-Chair of the Cervical Cancer Working Group of the Canadian Clinical Trials Group, and is an Executive Committee member of the CCTG Gyne Disease Site Group. She served as Special Expert of the NCI Gynecologic Cancer Steering Committee, and is currently Co-Chair, NCI NIH Cervical Cancer Task Force. In addition, she is Past-President of the Canadian Association of Radiation Oncology. Her clinical and research areas are in Gastrointestinal and Gynecologic cancers. This include clinical trials, investigating clinical and molecular factors of treatment resistance in cervical and anal cancers, and investigation of the microbiome in patients with cervical cancer.

Daniel Heng, MD, MPH, FRCPC

Clinical Professor and Head, Medical Oncology, University of Calgary
Head, Medical Oncology, Arthur JE Child Comprehensive Cancer Centre
Calgary, AB

Dr. Heng is a Staff Medical Oncologist at the Tom Baker Cancer Center in Calgary, Alberta and a Clinical Professor of Medicine at the University of Calgary. He received his MD from the University of Calgary and completed his internal medicine and medical oncology residencies at the University of British Columbia in Vancouver, BC. He was trained at the BC Cancer Agency in Vancouver, Canada and then completed an Experimental Therapeutics fellowship at the Cleveland Clinic Taussig Cancer Institute. He received a Masters of Public Health from Harvard University. He is the Division Head of Medical Oncology at the Arthur J.E Child Cancer Centre and University of Calgary and Chair of the International mRCC Consortium Database (www.IMDConline.com) which is the largest database of patients with metastatic kidney cancer treated with contemporary therapies in the world. He has a keen interest in outcomes, prognostic factors and clinical trials research in metastatic renal cell carcinoma and other genitourinary malignancies. He was awarded the Meritorious Service Cross by the Governor General of Canada for his work in Kidney Cancer.

Natalie Logie, MD, FRCP(C)

Radiation Oncologist, Department of Oncology, Alberta Health Services
Clinical Assistant Professor, University of Calgary
Calgary, AB

Dr. Natalie Logie is a Radiation Oncologist in the Department of Oncology at Alberta Health Services and is a Clinical Assistant Professor at the University of Calgary. She received her MD at the University of Alberta (2011) and completed residency at the University of Alberta in Radiation Oncology (2016) followed by fellowship specializing in pediatric radiation oncology and proton therapy at the University of Florida Proton Institute, Jacksonville (2017). She is dual certified radiation oncologist in both Canada (FRCPC) and USA (DABR).

She has an interest in both pediatric and AYA oncology outcomes/survivorship and is active in clinical outcomes research with work published in medical journals and textbooks. Dr. Logie has presented her research at peer-reviewed conferences such as the Pediatric Radiation Oncology Society (PROS) and American Society for Radiation Oncology (ASTRO), where she was awarded “Best Oral Presentation” at PROS in 2024, “Best Poster Session” at PROS in 2017, and “Best of ASTRO” in 2015.

Dr. Logie holds leadership positions within AHS, acting as the Breast and Pediatric Tumor Team RT Lead for Calgary and is the Co-Chair for the Provinicial Pediatric Tumor Team. She is Assistant Program Director for the University of Calgary radiation oncology residency program.

José Monzon, MD

Medical Director of Clinical Research Unit,
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, AB

Randeep Sangha, MD, FRCPC

Associate Professor, University of Alberta
Medical Oncologist, Cross Cancer Institute
Director, Clinical Trials Unit, Cross Cancer Institute
Provincial Lead, Alberta Lung Cancer Program
Edmonton, AB

Randeep Sangha, MD, is an Associate Professor at the University of Alberta and a Medical Oncologist at the Cross Cancer Institute in Edmonton, Alberta, Canada.

Dr. Sangha obtained his medical degree from the University of Alberta Faculty of Medicine, where he also completed his his residency in Internal Medicine and Medical Oncology. He then pursued a post-training research fellowship at the University of California, Davis Comprehensive Cancer Center, focusing on thoracic malignancies.

Dr. Sangha is the Director of the Clinical Trials Unit at the Cross Cancer Institute. He also has been the Provincial Lead for the Alberta Lung Cancer Program. His clinical and research interests include treatment of thoracic and hematologic malignancies, as well as developmental and molecular therapeutics.

Ankur M. Sharma, MD MPH FRCPC DABR

Radiation Oncologist, Central Alberta Cancer Centre
Medical Director, Community Oncology
Associate Senior Medical Director, Cancer Care Alberta
Clinical Assistant Professor, U of C Cumming School of Medicine, Department of Oncology
Assistant Clinical Professor, U of A Faculty of Medicine and Dentistry, Department of Oncology
Calgary, AB

Dr. Sharma graduated from the University of Saskatchewan Medical School prior to pursuing his residency training in Radiation Oncology at the University of Manitoba. He then completed the combined research/clinical Nancy K. Welker Fellowship in Advanced Radiation Modalities (proton radiotherapy, hyperthermia and GammaPod) at the University of Maryland in Baltimore where he served as a Visiting Instructor.

He worked as a staff Radiation Oncologist at Methodist University, Baptist Memorial and Saint Francis (Bartlett) Hospitals in Memphis, Tennessee where he specialized in treating GU, GI and Breast cancers with a research focus on SBRT/SABR and MRI guided radiotherapy. While there, he established a prostate SBRT program. He also served as Associate Director of the Radiation Oncology Residency Program at the University of Tennessee where he was an Assistant Professor.

Dr. Sharma has completed a Master’s Degree in Public Health from Harvard University at the T.H Chan School of Public Health.

He currently works as a Radiation Oncologist at the Central Alberta Cancer Centre in Red Deer where he treats GU, breast, GI and thoracic malignancies with special focus on palliative radiotherapy, SBRT/SABR and sarcoma. He established a prostate SBRT/SABR program in March of 2022 which is the largest of its kind in the province. He also serves as Chairman of the Central Alberta Cancer Centre GI Disease Site Group.